125 Series A medtech investors
We list 125 Series A medtech investors as of November 2026: 78 have an SEC filing on file and 47 were checked on the firm's own website or an official register, and the list was last checked on 7 Nov 2026. The states with the most are California (24), New York (8) and Massachusetts (7).
Top 5 Series A medtech investors, ranked by recent fund activity
Among firms with a published profile and a dated fund or deal in the last 24 months. The rule: Activity score out of 100: recency of the latest fund filing or dated deal (35: full marks within 3 months, then stepping down at 6, 12 and 24 months), share of the observed portfolio in this sector (25; half of that when the sector is stated only), stage focus (15: all of it when Series A is the only stage the firm states, split evenly when it states more), size of the fund on file on a log scale (15) and completeness of the public record (10). Stage focus is our research, not an SEC figure. It is a measure of activity and fit, not of quality or returns. The same rule orders the whole list; it is repeated in the method box.
Mercia Asset Management
Type: Fund manager · HQ: Henley-in-Arden, United Kingdom · Stages: Seed, Series A, Growth · Focus: Medtech, Healthtech, Future of Work, AI · Latest activity: Portfolio news, Oct 2026 · Fund size or assets: £400M (own site)
Portfolio news dated Oct 2026; £400M on file (own site); 100% of its observed portfolio is medtech and medical devices; backs seed, Series A, growth-stage; 8 named decision-makers on file.
SHD Partners
Type: VC firm · HQ: Dallas, TX · Stages: Seed, Series A · Focus: Medtech, Healthtech, Biotech · Latest activity: Portfolio news, Nov 2026 · Private fund assets: $61M (SEC Form ADV)
Portfolio news dated Nov 2026; $61M on file (SEC Form ADV); 53% of its observed portfolio is medtech and medical devices; backs seed, Series A; 6 named decision-makers on file.
HC9 Ventures
Type: VC firm · HQ: Havertown, PA · Stages: Seed, Series A · Focus: Medtech, Healthtech, AI, Fintech · Latest activity: New fund, Oct 2026 · Fund size on file: $85M (SEC Form D, 2025)
Latest fund filing dated Oct 2026; $85M fund on file (SEC Form D, 2025); 81% of its observed portfolio is medtech and medical devices; backs seed, Series A; 3 named decision-makers on file.
BGF
Type: VC firm · HQ: United Kingdom · Stages: Seed, Series A, Series B, Growth · Focus: Medtech, Healthtech, Edtech, Developer Tools · Latest activity: Portfolio news, Oct 2026 · Fund size or assets: £3.0B (own site)
Portfolio news dated Oct 2026; £3.0B on file (own site); 40% of its observed portfolio is medtech and medical devices; backs seed, Series A, Series B; 8 named decision-makers on file.
25Madison Ventures
Type: VC firm · HQ: New York, NY · Stages: Pre-seed, Seed, Series A · Focus: Medtech, Healthtech, AI, Logistics · Latest activity: New fund, Oct 2026 · Fund size on file: $50M (SEC Form D, 2026)
Latest fund filing dated Oct 2026; $50M fund on file (SEC Form D, 2026); 55% of its observed portfolio is medtech and medical devices; backs pre-seed, seed, Series A; 8 named decision-makers on file.
First 25 of 125 Series A medtech investors
| Investor | Type | HQ | Stagesour research | Focusour research | Latest fund or deal | Fund sizeas filed or stated | Checked | Contacts |
|---|---|---|---|---|---|---|---|---|
| Mercia Asset Management | Fund manager | Henley-in-Arden, United Kingdom | Seed, Series A, Growth | Medtech, Healthtech, Future of Work, AI | Portfolio news, Oct 2026 | £400M (own site) | 4 Nov 2026 | 8 names, firm email · Unlock |
| SHD Partners | VC firm | Dallas, TX | Seed, Series A | Medtech, Healthtech, Biotech | Portfolio news, Nov 2026 | $61M (SEC Form ADV) | 5 Nov 2026 | 6 names, firm email · Unlock |
| HC9 Ventures | VC firm | Havertown, PA | Seed, Series A | Medtech, Healthtech, AI, Fintech | New fund, Oct 2026 | $85M (SEC Form D, 2025) | 4 Nov 2026 | 3 names · Unlock |
| BGF | VC firm | United Kingdom | Seed, Series A, Series B, Growth | Medtech, Healthtech, Edtech, Developer Tools | Portfolio news, Oct 2026 | £3.0B (own site) | 4 Nov 2026 | 8 names · Unlock |
| 25Madison Ventures | VC firm | New York, NY | Pre-seed, Seed, Series A | Medtech, Healthtech, AI, Logistics | New fund, Oct 2026 | $50M (SEC Form D, 2026) | 4 Nov 2026 | 8 names, firm email · Unlock |
| IW Capital | SEIS/EIS fund | London, United Kingdom | Series A | Medtech, Healthtech, AI, SaaS | New deal, Oct 2026 | £185M (own site) | 4 Nov 2026 | 8 names, firm email · Unlock |
| Claritas Signal Partners | VC firm | Nashville, TN | Seed, Series A, Series B, Growth | Medtech, Healthtech, AI, Media | New deal, Aug 2026 | $14M (SEC Form D, 2021) | 5 Nov 2026 | 8 names · Unlock |
| Parkwalk Advisors | SEIS/EIS fund | London, United Kingdom | Seed, Series A, Series B, Growth | Medtech, Healthtech, AI, Industrial Tech | New fund, Sep 2026 | £500M (own site) | 4 Nov 2026 | 8 names, firm email · Unlock |
| Angelor | VC firm | Lyon, France | Seed, Series A | Medtech, Healthtech, Biotech, Food and Beverage | New deal, Sep 2026 | €100M (own site) | 7 Nov 2026 | 1 name · Unlock |
| HBM Partners | Fund manager | Zug, Switzerland | Series A, Series B, Growth, Late stage | Medtech, Healthtech, Biotech | Portfolio news, Oct 2026 | $2.8B (own site) | 7 Nov 2026 | 1 name, firm email · Unlock |
| Khosla Ventures | VC firm | Menlo Park, CA | Pre-seed, Seed, Series A, Growth | Medtech, AI, Consumer, B2B | New fund, Aug 2026 | $1.9B (SEC Form D, 2025) | 4 Nov 2026 | 8 names · Unlock |
| Andera Partners | Fund manager | Paris, France | Seed, Series A, Series B, Growth | Medtech, Biotech, Healthtech, Generalist | Portfolio news, Sep 2026 | €6.0B (own site) | 7 Nov 2026 | No contact on file |
| FCA Venture Management Group | VC firm | Nashville, TN | Seed, Series A, Series B | Medtech, Healthtech, AI, Biotech | Portfolio news, May 2026 | $58M (SEC Form ADV) | 5 Nov 2026 | 8 names · Unlock |
| Star51 Capital | VC firm | New York, NY | Seed, Series A, Series B, Growth | Medtech, Healthtech, AI, Robotics | New deal, Sep 2026 | 4 Nov 2026 | 3 names, firm email · Unlock | |
| Felicis | VC firm | Menlo Park, CA | Seed, Series A | Medtech, AI, Developer Tools, Healthtech | New deal, Oct 2026 | $900M (SEC Form D, 2025) | 5 Nov 2026 | 8 names · Unlock |
| Hadean Ventures | VC firm | Norway | Seed, Series A, Series B | Medtech, Healthtech, Biotech | New deal, Sep 2026 | €230M (own site) | 7 Nov 2026 | 3 names, firm email · Unlock |
| Sandbox Clinical Ventures | VC firm | Chicago, IL | Seed, Series A, Series B, Growth | Medtech, Insurtech, Healthtech, AI | New fund, Sep 2026 | $100M (SEC Form D, 2021) | 4 Nov 2026 | 8 names, firm email · Unlock |
| 819 Capital Partners | VC firm | Deventer, Netherlands | Seed, Series A, Growth | Medtech, Healthtech, Biotech, Generalist | Portfolio news, Sep 2026 | €100M (own site) | 7 Nov 2026 | 1 name, firm email · Unlock |
| Roo Capital | VC firm | Coconut Grove, FL | Pre-seed, Seed, Series A, Growth | Medtech, AI, Healthtech, Future of Work | New fund, Aug 2026 | $125M (SEC Form D, 2026) | 4 Nov 2026 | 8 names, firm email · Unlock |
| Balderton Capital | VC firm | London, United Kingdom | Seed, Series A, Series B, Growth | Medtech, Healthtech, AI, Fintech | Portfolio news, Oct 2026 | $5.7B (own site) | 4 Nov 2026 | 8 names · Unlock |
| Cybernetix Ventures | VC firm | Boston, MA | Pre-seed, Seed, Series A | Medtech, Robotics, Industrial Tech, Logistics | New fund, Aug 2026 | $100M (SEC Form D, 2025) | 4 Nov 2026 | 2 names · Unlock |
| Cultivation Capital | VC firm | St. Louis, MO | Seed, Series A, Series B | Medtech, Healthtech, Biotech, SaaS | New fund, Sep 2026 | $100M (SEC Form D, 2022) | 4 Nov 2026 | 8 names · Unlock |
| Healthier Capital | VC firm | Menlo Park, CA | Series A | Medtech, Healthtech, AI, SaaS | New fund, Nov 2025 | $200M (SEC Form D, 2024) | 4 Nov 2026 | 8 names · Unlock |
| Define Ventures | VC firm | San Francisco, CA | Pre-seed, Seed, Series A, Series B | Medtech, Healthtech, AI, Future of Work | New deal, Apr 2026 | $425M (SEC Form D, 2022) | 5 Nov 2026 | 8 names · Unlock |
| Cornucopian Capital | VC firm | Montclair, NJ | Pre-seed, Seed, Series A, Series B | Medtech, Healthtech, AI, Biotech | New fund, Aug 2026 | $12M (SEC Form D, 2024) | 4 Nov 2026 | 1 name · Unlock |
You are seeing 25 of 125. The full list adds 100 more investors and 643 named decision-makers.
One-time payment. No subscription. No account.
Or get the free sample.
How these 125 break down
By region
| Region | On this list | Share |
|---|---|---|
| United States | 76 | 61% |
| United Kingdom | 25 | 20% |
| Europe | 24 | 19% |
By US state
| US state | On this list | Share |
|---|---|---|
| California | 24 | 19% |
| New York | 8 | 6% |
| Massachusetts | 7 | 6% |
| Tennessee | 5 | 4% |
| Texas | 4 | 3% |
| Pennsylvania | 4 | 3% |
| Illinois | 4 | 3% |
| New Jersey | 3 | 2% |
| Florida | 2 | 2% |
| Michigan | 2 | 2% |
By European country
| European country | On this list | Share |
|---|---|---|
| France | 5 | 4% |
| Netherlands | 5 | 4% |
| Germany | 3 | 2% |
| Switzerland | 2 | 2% |
| Italy | 2 | 2% |
| Sweden | 2 | 2% |
By type
| Type | On this list | Share |
|---|---|---|
| VC firm | 108 | 86% |
| Fund manager | 9 | 7% |
| Corporate VC | 3 | 2% |
| SEIS/EIS fund | 2 | 2% |
| Angel network | 2 | 2% |
Method and limits
- Source
- 78 of the 125 rows carry an SEC filing (Form D or Form ADV). All 125 have a website we checked. Filing date and fund size are SEC data where a filing exists. Stage, sector and check size are our research.
- Inclusion rule
- Organizations that back startups. Individuals, buyout funds and firms we found to be inactive are left out. Sector: the firm states medtech and medical devices as a focus on its own site, or we observed it in the firm's portfolio. Stage: the firm states that it invests at Series A.
- Order
- Firms with a published profile come first. Activity score out of 100: recency of the latest fund filing or dated deal (35: full marks within 3 months, then stepping down at 6, 12 and 24 months), share of the observed portfolio in this sector (25; half of that when the sector is stated only), stage focus (15: all of it when Series A is the only stage the firm states, split evenly when it states more), size of the fund on file on a log scale (15) and completeness of the public record (10). Stage focus is our research, not an SEC figure. It is a measure of activity and fit, not of quality or returns.
- Last refreshed
- November 2026. Rows on this list were checked between 4 Nov 2026 and 7 Nov 2026.
- Fill rates
- Of 125 rows: stage 125, sector 125, fund size 93, website 125. In the paid file: named decision-makers on 117 rows, firm email on 66, LinkedIn page on 88, check size on 33.
- Corrections
- Email [email protected] or use the update form. We act within 5 working days.
Questions
How many Series A medtech investors are there?
We list 125 as of November 2026. 64 of the 125 have a fund filing or a dated deal in the last 12 months.
Which Series A medtech investors raised a new fund in the last 12 months?
24 of the 125 have a fund filing dated in the last 12 months. The most recent on this list are 25Madison Ventures (Oct 2026), Switchboard (Oct 2026) and HC9 Ventures (Oct 2026).
What is the typical fund size of Series A medtech investors?
The median fund size on file for this list is $88M, across the 50 firms with a size on an SEC Form D. The fund on file is each firm's main fund, which is not always its newest. The other 75 do not disclose a size there.
How do I contact Series A medtech investors?
The paid file holds 643 named decision-makers across 117 of these 125 and a firm email for 66. We publish the address a firm lists itself, never a personal email. Each free row links to a profile with the firm's website.
Where does the data on Series A medtech investors come from?
78 of the 125 rows have an SEC filing on file (Form D or Form ADV) and 47 were checked on the firm's own website or an official register. Filing date and fund size come from the filing. Stage, sector and check size are our research. Rows on this list were last checked on 7 Nov 2026 at the latest. The whole file is re-verified twice a year.
Broader lists
Narrower lists
Related lists
Series A AI investors (500)Series A SaaS investors (475)Series A healthtech investors (401)Series A fintech investors (294)Series A deep tech investors (293)Seed medtech investors (278)Series A climate tech investors (263)Series A B2B investors (157)Series A consumer investors (154)Series A biotech investors (153)Series A energy investors (139)Pre-seed medtech investors (129)Series A cybersecurity investors (118)Series A industrial tech investors (113)Growth-stage medtech investors (107)Series A hardware investors (82)Series A mobility investors (70)Series A developer tools investors (67)
Not sure this is the right list? Describe your raise in the investor matching tool and get a shortlist. The link opens it set to medtech and medical devices and Series A. Guide: how many investors to pitch. Markdown version of this page.
Check the quality first
A free sample of 100 investors, every column, with sources and dates.